4//SEC Filing
Bankier Alain D 4
Accession 0001214659-18-004985
CIK 0001625288other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 11:38 AM ET
Size
9.7 KB
Accession
0001214659-18-004985
Insider Transaction Report
Form 4
Bankier Alain D
Director
Transactions
- Award
Stock option - right to buy
2018-07-25+840,000→ 840,000 totalExercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (840,000 underlying) - Award
Stock option - right to buy
2018-07-25+100,000→ 100,000 totalExercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (100,000 underlying)
Holdings
- 28,000
Class C Warrants (right to buy)
Exercise: $0.50From: 2017-11-29Exp: 2018-07-27→ Common Stock (28,000 underlying) - 2,256,000
Common Stock
Footnotes (3)
- [F1]70,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
- [F2]Granted under the Company's 2018 Equity Incentive Plan.
- [F3]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
Documents
Issuer
Intiva BioPharma Inc.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001719591
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 11:38 AM ET
- Size
- 9.7 KB